Product description

Bacitracin is composed of a group of polypeptides with antibiotic activity against a variety of Gram-positive bacteria including
staphylococci.

Indication: Used locally for the treatment of infections of the skin, ear and eye or for intramuscular use in infants for the
treatment of pneumonia and empyema caused by susceptible staphylococci.

Application: Administered typically as a combination drug product used in topical creams, powders, ointments and
solutions. Bacitracin is also administered systemically as intramuscular injections.

Shelf-life: Non-sterile: 4 years Sterile: 3 years

Storage conditions:
Below 8°C (46°F) Other documentation Written confirmation for import into EU
Chinese manufacturing license (Taizhou site)

For further information contact us at [email protected] 

or access our product sheet online https://xellia.com/products/Bacitracin/ 


Read more

More products from Xellia Pharmaceuticals ApS

View all our products (22)

Products from other suppliers